Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Punica granatum + Crocus sativus herbal formulation vs azelaic acid for postinflammatory hyperpigmentation
IRCT20120215009014N450Phase 3Completed
- Sponsor
- Hamadan University of Medical Sciences
- Start
- Feb 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of Azelaic acid in Post-inflammatory hyperpigmentation (PIH) (2 arms), sponsored by Hamadan University of Medical Sciences. Started Feb 2023; status: completed.
02
Drugs
Azelaic acid
03
Conditions
Post-inflammatory hyperpigmentation (PIH)
Beyond the preview
Go deeper on IRCT20120215009014N450.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20120215009014N450.